GlaxoSmithKline - International Pharmaceutical Industry

News

Positive Phase III results for plant-based COVID-19 vaccine

Medicago and GlaxoSmithKline (GSK) have announced positive efficacy and safety results from the global Phase III placebo-controlled efficacy study of Medicago’s plan...

7 December 2021 News COVID-19 vaccine | GlaxoSmithKline

Continue Reading →

News

GSK aim for HIV cure by 2030

Following its recent approval of an injectable HIV-1 treatment from the National Institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hope...

1 December 2021 News GlaxoSmithKline | GSK

Continue Reading →

News

Positive results for GSK’s anaemia drug daprodustat

GlaxoSmithKline (GSK) has revealed positive data for its investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) daprodustat in patients...

9 November 2021 News anaemia | chronic kidney disease

Continue Reading →

News

GSK plans UK headquarters for new consumer healthcare company

GlaxoSmithKline is set to base its new consumer healthcare company in the UK following the separation of the business, planned in 2022. Under new proposals, the n...

13 October 2021 News GlaxoSmithKline | GSK

Continue Reading →

News

SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate

SK bioscience (SK) and GlaxoSmithKline plc (GSK) today announced the initiation of Phase 3 clinical study of SK's COVID-19 vaccine candidate, GBP510, in combination ...

1 September 2021 News AstraZeneca | COVID-19 vaccine

Continue Reading →

News

GSK considers splitting up

GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group. Accordi...

24 July 2018 News considers | GlaxoSmithKline

Continue Reading →